Both in Lab Analytical Instruments
Bruker vs 10x Genomics
Over the past year BRKR returned +62.9% and TXG returned +384.7%; their daily moves had a correlation of 0.55.
BRKR +62.9% TXG +384.7%Growth of $1, one year, split-adjusted
| Metric | BRKR | TXG |
|---|---|---|
| Price | $63.04 | $66.41 |
| Market cap | $9.60B | $8.65B |
| Today | +11.58% | +1.71% |
| 1 month | +4.2% | −17.7% |
| 6 months | +49.0% | +192.0% |
| Year to date | +33.8% | +307.1% |
| 1 year | +62.9% | +384.7% |
| Revenue growth (YoY) | +5.2% | −12.6% |
| Gross margin | 49.6% | 74.5% |
| Net margin | −7.5% | −11.9% |
| P/E (TTM) | — | — |
| Price / sales | 2.7× | 14.0× |
| Net cash | -$1.64B | $552.0M |
| Dividend yield | 0.32% | — |
| Volatility (60d) | 55.5% | 85.8% |
| Short % of float | 11.4% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).